CG
VIR icon

Cutler Group’s Vir Biotechnology VIR Stock Holding History

Cutler Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-410
Closed -$10.4K – 5572
2022
Q2 		$10K Buy
+410
New +$9.57K ﹤0.01% 3223
2022
Q1 		– Sell
-5,637
Closed -$167K – 6109
2021
Q4 		$236K Sell
5,637
-5,261
-48% -$206K 0.01% 1188
2021
Q3 		$474K Buy
10,898
+10,800
+11,020% +$468K 0.02% 820
2021
Q2 		$4K Buy
+98
New +$4.46K ﹤0.01% 4651
2021
Q1 		– Sell
-6
Closed -$323 – 6346
2020
Q4 		$0 Sell
6
-2,880
-100% -$93.6K ﹤0.01% 5545
2020
Q3 		$99K Buy
2,886
+2,416
+514% +$104K 0.01% 1334
2020
Q2 		$19K Buy
+470
New +$15.8K ﹤0.01% 2436

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return